Literature DB >> 19297612

Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study.

Craig S Wong1, Christopher B Pierce, Stephen R Cole, Bradley A Warady, Robert H K Mak, Nadine M Benador, Fredrick Kaskel, Susan L Furth, George J Schwartz.   

Abstract

BACKGROUND AND OBJECTIVES: Proteinuria is associated with chronic kidney disease (CKD), and heavy proteinuria predicts a rapid decline in kidney function. However, the epidemiologic distribution of this important biomarker study is not well described in the pediatric CKD population. DESIGN, SETTING, PARTICIPANTS & MEASUREMENTS: This cross-sectional study of North American children with CKD examined the association of proteinuria among the baseline clinical variables in the cohort. Urinary protein-to-creatinine ratios (Up/c) were used to measure level of proteinuria.
RESULTS: Of the 419 subjects studied, the median GFR as measured by iohexol disappearance (iGFR) was 42 ml/min per 1.73 m(2), median duration of CKD was six yr, and glomerular diseases accounted for 22% of the CKD diagnoses. Twenty-four percent of children had normal range (Up/c <0.2), 62% had significant, and 14% had nephrotic-range proteinuria (Up/c >2.0). A decrease in iGFR was associated with an increase in Up/c. At any level of GFR, a higher Up/c was associated with a glomerular cause of CKD and non-Caucasian race. Among subjects with a glomerular cause of CKD, Up/c was lower in subjects reporting utilization of renin-angiotensin system (RAS) antagonists (median Up/c = 0.93) compared with those who did not (median Up/c = 3.78).
CONCLUSIONS: Proteinuria is associated with level of iGFR, cause of CKD, and race. The longitudinal study design of Chronic Kidney Disease in Children (CKiD) cohort study and the large number of subjects being studied has created an opportunity to better define the association between proteinuria and CKD progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297612      PMCID: PMC2666424          DOI: 10.2215/CJN.01780408

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  32 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  Confounding by indication in epidemiologic studies of commonly used analgesics.

Authors:  Lisa B Signorello; Joseph K McLaughlin; Loren Lipworth; Søren Friis; Henrik Toft Sørensen; William J Blot
Journal:  Am J Ther       Date:  2002 May-Jun       Impact factor: 2.688

Review 3.  Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications.

Authors:  E Hak; Th J M Verheij; D E Grobbee; K L Nichol; A W Hoes
Journal:  J Epidemiol Community Health       Date:  2002-12       Impact factor: 3.710

4.  Effect of ramipril on ambulatory blood pressure and albuminuria in renal hypertension.

Authors:  M Soergel; M Verho; E Wühl; J Gellermann; L Teichert; K Schärer
Journal:  Pediatr Nephrol       Date:  2000-11       Impact factor: 3.714

5.  Evidence from nonrandomized studies: a case study on the estimation of causal effects.

Authors:  Claudia Schmoor; Angelika Caputo; Martin Schumacher
Journal:  Am J Epidemiol       Date:  2008-03-11       Impact factor: 4.897

6.  Racial differences in microalbumin excretion in healthy adolescents.

Authors:  Coral D Hanevold; Jennifer S Pollock; Gregory A Harshfield
Journal:  Hypertension       Date:  2008-01-02       Impact factor: 10.190

7.  Epidemiology of chronic renal failure in children: data from the ItalKid project.

Authors:  Gianluigi Ardissino; Valeria Daccò; Sara Testa; Roberto Bonaudo; Aldo Claris-Appiani; Emanuela Taioli; Giuseppina Marra; Alberto Edefonti; Fabio Sereni
Journal:  Pediatrics       Date:  2003-04       Impact factor: 7.124

8.  Comparison of two methods for transforming height and weight to normality.

Authors:  A Pere
Journal:  Ann Hum Biol       Date:  2000 Jan-Feb       Impact factor: 1.533

9.  Exploring relative mortality and epoetin alfa dose among hemodialysis patients.

Authors:  Brian D Bradbury; Ouhong Wang; Cathy W Critchlow; Kenneth J Rothman; Patrick Heagerty; Marcia Keen; John F Acquavella
Journal:  Am J Kidney Dis       Date:  2008-01       Impact factor: 8.860

Review 10.  Pathophysiology of proteinuria.

Authors:  Giuseppe D'Amico; Claudio Bazzi
Journal:  Kidney Int       Date:  2003-03       Impact factor: 10.612

View more
  60 in total

Review 1.  Management of proteinuria in the transplanted patient.

Authors:  Tomáš Seeman
Journal:  Pediatr Nephrol       Date:  2014-08-27       Impact factor: 3.714

Review 2.  Proteinuria and progression of pediatric chronic kidney disease: lessons from recent clinical studies.

Authors:  Sahar A Fathallah-Shaykh
Journal:  Pediatr Nephrol       Date:  2016-06-27       Impact factor: 3.714

3.  Time-varying coefficient of determination to quantify the explanatory power of biomarkers on longitudinal GFR among children with chronic kidney disease.

Authors:  Derek K Ng; Anthony A Portale; Susan L Furth; Bradley A Warady; Alvaro Muñoz
Journal:  Ann Epidemiol       Date:  2018-05-17       Impact factor: 3.797

4.  Estimating Time to ESRD in Children With CKD.

Authors:  Susan L Furth; Chris Pierce; Wun Fung Hui; Colin A White; Craig S Wong; Franz Schaefer; Elke Wühl; Alison G Abraham; Bradley A Warady
Journal:  Am J Kidney Dis       Date:  2018-04-10       Impact factor: 8.860

5.  A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program.

Authors:  Debora C Cerqueira; Cristina M Soares; Vanessa R Silva; Juliana O Magalhães; Isabella P Barcelos; Mariana G Duarte; Sergio V Pinheiro; Enrico A Colosimo; Ana Cristina Simões e Silva; Eduardo A Oliveira
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 8.237

6.  Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.

Authors:  Sahar A Fathallah-Shaykh; Joseph T Flynn; Christopher B Pierce; Alison G Abraham; Tom D Blydt-Hansen; Susan F Massengill; Marva M Moxey-Mims; Bradley A Warady; Susan L Furth; Craig S Wong
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-29       Impact factor: 8.237

7.  Neurocognitive functioning of children and adolescents with mild-to-moderate chronic kidney disease.

Authors:  Stephen R Hooper; Arlene C Gerson; Robert W Butler; Debbie S Gipson; Susan R Mendley; Marc B Lande; Shlomo Shinnar; Alicia Wentz; Matthew Matheson; Christopher Cox; Susan L Furth; Bradley A Warady
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

8.  A clinical predictive model of chronic kidney disease in children with posterior urethral valves.

Authors:  Mariana A Vasconcelos; Ana Cristina Simões E Silva; Izabella R Gomes; Rafaela A Carvalho; Sergio V Pinheiro; Enrico A Colosimo; Peter Yorgin; Robert H Mak; Eduardo A Oliveira
Journal:  Pediatr Nephrol       Date:  2018-09-08       Impact factor: 3.714

9.  Chapter 1: Definition and classification of CKD.

Authors: 
Journal:  Kidney Int Suppl (2011)       Date:  2013-01

10.  Contribution of symmetric dimethylarginine to GFR decline in pediatric chronic kidney disease.

Authors:  Ellen R Brooks; Shannon Haymond; Alfred Rademaker; Christopher Pierce; Irene Helenowski; Rod Passman; Faye Vicente; Bradley A Warady; Susan L Furth; Craig B Langman
Journal:  Pediatr Nephrol       Date:  2017-12-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.